<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To evaluate the incidences of and risk factors predisposing to appropriate and inappropriate shocks and mortality in a 'real-world' population of patients with <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e>) and implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) for primary prevention of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> (SCD).METHODS AND RESULTS: In this nationwide cohort, we prospectively followed 1609 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> and left ventricular dysfunction from the Danish <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> Register who received an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> for primary prevention of SCD (1 January 2007 to 30 November 2011) </plain></SENT>
<SENT sid="1" pm="."><plain>Primary study outcomes were appropriate shocks, inappropriate shocks, and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
<SENT sid="2" pm="."><plain>Secondary study outcomes included the composite endpoints: appropriate therapy and inappropriate therapy (defined as shock or anti-<z:hpo ids='HP_0001649'>tachycardia</z:hpo> pacing) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo>-cause mortality was 12.1% during a mean follow-up time of 1.9 Â± 1.3 years </plain></SENT>
<SENT sid="4" pm="."><plain>Inappropriate shocks and therapy occurred in 2.6% and 3.7% during follow-up, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Appropriate shocks and therapy was identified in 7.8% and 13.4%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Time-dependent multivariable Cox regression analyses were used to identify risk factors of inappropriate/appropriate shock, therapy and mortality </plain></SENT>
<SENT sid="7" pm="."><plain>Implantation of a dual-chamber <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> was associated with increased risk of both inappropriate shocks and any inappropriate therapy compared to single-chamber <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> [hazard ratios (HR) = 2.45; confidence intervals (CI):1.16-5.14 and HR = 2.38; CI:1.28-4.42, respectively] </plain></SENT>
<SENT sid="8" pm="."><plain>No excess risk of mortality was associated with any device type.CONCLUSION: In this nationwide study of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> patients with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> for primary prevention of SCD, the incidence of appropriate shocks as well as inappropriate shocks were significantly lower than reported in randomized trials </plain></SENT>
<SENT sid="9" pm="."><plain>Implantation of a dual-chamber <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> was associated with more inappropriate shocks compared with single chamber devices </plain></SENT>
</text></document>